We are one of the leading diagnostics companies in India, by revenue, as of March 31, 2018 (Source: Frost & Sullivan). We have widespread presence across 18 states in India, as of March 31, 2018, with leadership position in west and south India (Source: Frost & Sullivan). Through our widespread operational network, we offer a comprehensive range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.
We also offer analytical and support services to clinical research organizations for their clinical research projects. During the financial year 2018, we conducted approximately 16.0 million tests from approximately 7.7 million patient visits. We offer a broad range of approximately 3,480 clinical laboratory tests and 524 profiles, as of March 31, 2018. The profile comprises of a variety of test combinations which are specific to a disease or disorder as well as wellness profiles that are used for health and fitness screening.
We also offer analytical and support services to clinical research organizations for their clinical research projects. During the financial year 2018, we conducted approximately 16.0 million tests from approximately 7.7 million patient visits. We offer a broad range of approximately 3,480 clinical laboratory tests and 524 profiles, as of March 31, 2018. The profile comprises of a variety of test combinations which are specific to a disease or disorder as well as wellness profiles that are used for health and fitness screening.
Metropolis Healthcare Limited IPO Details
|
|
---|---|
Issue Open | 03-04-2019 |
Issue Close | 05-04-2019 |
Allotment Date | 10-04-2019 |
Unblocked Amount | 11-04-2019 |
Listing Date | 12-04-2019 |
Issue Size |
13,685,095 Total Equity Share
- Fresh Issue Equity Share - OFS Equity Share |
Issue Size | ₹ 1204 Cr ₹ - Cr Fresh ₹ - Cr OFS |
IPO Price Band | ₹ 877-880 |
Minimum Share Bid | 17 |
Minimum Investment Amount [₹] | ₹ 14,960 |
Face Value | ₹ 2 |
Qualified Institutional Buyer [QIB] | 50% |
High Networth Individual [HNI] | 15% |
Retail Individual Investor [RII] | 35% |
Listing On | BSE & NSE |
Metropolis Healthcare Limited IPO Grey Market Premium GMP]
|
||||
---|---|---|---|---|
Latest Update | Premium | Kostak | Subject to Sauda | Recommended |
29-03-2019 : 08:00 AM | - | - | 1500 | Apply |
Metropolis Healthcare Limited IPO Financial details [in Rs, Cr]
|
||||
---|---|---|---|---|
Financial Year | Total Asset | Total Revenue | Total Expenses | Profit After Tax |
FY-2014 | - | - | - | - |
FY-2015 | - | - | - | - |
FY-2016 | 395.92 | 490.63 | 366.42 | 81.96 |
FY-2017 | 515.16 | 567.65 | 410.39 | 107.26 |
FY-2018 | 530.34 | 651.55 | 491.25 | 109.75 |
31-12-2018 | 583.87 | 566.82 | 431.15 | 88.78 |
Metropolis Healthcare Limited IPO Valuation Details
|
|
---|---|
Earnings Per Share [EPS] | ₹ 20.61 |
Price/Earnings [P/E] Ratio | 40.23 |
Return on Net Worth [RoNW] | 24.66 % |
Net Asset Value [NAV] | ₹ 83.58 Per Share |
Metropolis Healthcare Limited IPO Subscription Details
|
|||||
---|---|---|---|---|---|
As on Date | QIB | NII | RII | Employee | Total |
Shared Offered | 1,32,00,000 | 26,40,000 | 17,60,000 | 70,000 | 1,76,70,400 |
Day-1 [03-04-2019] |
3,57,306 [0.09] |
7,072 [0.00] |
3,35,903 [0.25] |
1,003 [0.00] |
7,01,284 [0.09] |
Day-2 [04-04-2019] |
25,91,446 [0.65] |
45,951 [0.02] |
9,33,164 [0.70] |
2,839 [0.01] |
35,73,400 [0.47] |
Day-3 [05-04-2019] |
3,56,53,386 [8.88] |
60,86,306 [3.03] |
28,55,303 [2.13] |
16,235 [0.05] |
4,46,11,230 [5.82] |
Metropolis Healthcare Limited IPO Grey Market Premium
|
---|
Check Grey Market Premium :- Click Here |
Metropolis Healthcare Limited IPO Allotment Status
|
---|
Check Allotment Status :- Click Here |
Live Subscription for Lodha Developers Limited IPO
|
---|
Check Live Subscription in BSE :- Click Here Check Live Subscription in NSE :- Click Here |
Download Metropolis Healthcare Limited IPO RHP & ASBA e-Forms
|
---|
Download RHP :- Click Here to Download Download e-Forms BSE:- Click Here to Download Download e-Forms NSE:- Click Here to Download |
Metropolis Healthcare Limited IPO Recommendations
|
---|
Live IPO Team Recommendation:- Apply |
Metropolis Healthcare Limited IPO Contact Details
|
---|
Metropolis Healthcare Limited
250 D Udyog Bhavan, Hind Cycle Marg, Worli, Mumbai 400 030, Maharashtra, India; Tel: (91 22) 6258 2810 E-mail: investor.relations@metropolisindia.com Website: www.metropolisindia.com Corporate Identity Number: U73100MH2000PLC192798 |
Registrar of Metropolis Healthcare Limited IPO
|
---|
Link Intime India Private Limited
C-101, 1st floor, 247 Park L B S Marg, Vikhroli, West Mumbai 400 083 Tel: (91 22) 4918 6200 Facsimile: (91 22) 4918 6195 E-mail: metropolis.ipo@linkintime.co.in Investor grievance e-mail: metropolis.ipo@linkintime.co.in Website: www.linkintime.co.in Contact Person: Shanti Gopalkrishnan SEBI Registration No.: INR000004058 |
Lead Managers of Metropolis Healthcare Limited IPO
|
---|
JM Financial Limited
7th Floor, Cnergy Appasaheb Marathe Marg Prabhadevi Mumbai 400 025 Tel: (91 22) 6630 3030 Facsimile: (91 22) 6630 3330 Email: metropolis.ipo@jmfl.com Investor Grievance Email: grievance.ibd@jmfl.com Website: www.jmfl.com Contact Person: Prachee Dhuri SEBI Registration Number: INM000010361 Credit Suisse Securities (India) Private Limited^ 9th Floor, Ceejay House Dr. Annie Besant Road, Worli, Mumbai 400 018 Tel: (91 22) 6777 3885 Facsimile: (91 22) 6777 3820 Email: list.metropolisipo@credit-suisse.com Investor Grievance Email: list.metropolisipo@credit-suisse.com Website: www.credit-suisse.com Contact Person: Chunky Shah SEBI Registration Number: INM000011161 Goldman Sachs (India) Securities Private Limited Rational House 951-A, Appasaheb Marathe Marg, Prabhadevi Mumbai 400 025 Tel: (91 22) 6616 9000 Facsimile: (91 22) 6616 9001 Email: gs-metropolis-ipo@gs.com Investor Grievance Email: india-client-support@gs.com Website: www.goldmansachs.com Contact Person: Sonam Chopra SEBI Registration Number: INM000011054 HDFC Bank Limited Investment Banking Group Unit No. 401 & 402, 4th Floor Tower B, Peninsula Business Park, Lower Parel Mumbai 400 013 Tel: (91 22) 3395 8233 Facsimile: (91 22) 3078 8584 E-mail: metropolis.ipo@hdfcbank.com Investor Grievance e-mail:investor.redressal@hdfcbank.com Website: www.hdfcbank.com Contact Person: Ravi Sharma SEBI Registration No.: INM000011252 Kotak Mahindra Capital Company Limited 1st Floor, 27 BKC, Plot No. 27 G Block, Bandra Kurla Complex Bandra (East) Mumbai 400 051 Tel: (91 22) 4336 0000 Facsimile: (91 22) 6713 2447 Email: metropolis.ipo@kotak.com Investor Grievance Email: kmccredressal@kotak.com Website: www.investmentbank.kotak.com Contact Person: Ganesh Rane SEBI Registration Number: INM000008704 |
Disclaimer:-
|
---|
• I request all investors, before applying for any IPO, please check the fundamentals and financial condition of the company and then applying to any IPO.
• www.liveipo.in will not be responsible for any kind of losses. So apply to any IPO at your risk
• We are not buying or selling any IPO forms regarding IPO Grey Market premium. We are only provide only recommendation of any IPO.
• Please do not subscribe to any IPO by just seeing the Grey Market Premium Price. It can change at any time.
|
0 Response to "Metropolis Healthcare Limited IPO Details"
Post a Comment